Lockheed Martin Investment Management CO Teva Pharmaceutical Industries LTD Transaction History

Lockheed Martin Investment Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $167,700 - $247,100	-10,000 Closed	0 $0
Q4 2017 Jan 18, 2018	SELL	$11.23 - $19.1 $89,840 - $152,800	-8,000 Reduced 44.44%	10,000 $189,000
Q3 2017 Nov 06, 2017	BUY	$15.41 - $32.17 $277,380 - $579,060	18,000	18,000 $317,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Lockheed Martin Investment Management CO with notifications on news.